Tofacitinib Impurity 69

Product Name
Tofacitinib Impurity 69
Chemical Name
Tofacitinib Impurity 69
Synonyms
Tofacitinib Impurity 69;(E)-2,4-dichlorobut-2-enal
CBNumber
CB44657804
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

Tofacitinib Impurity 69 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tofacitinib Impurity 69 Suppliers

China 5 United States 1 Global 6
Shenzhen SUNGENING Bio-Medical Co., Ltd.
Tel
0755-0755-28967200-8062 13631290199
Fax
0755-28967200
Email
wxf@sungening.com
Country
China
ProdList
9624
Advantage
60
Cato Research Chemicals Inc.
Tel
+86-020-81960175-877 4000-868-328
Email
tianwen.zhan@cato-chem.com
Country
United States
ProdList
10404
Advantage
58
Changzhou Xianglong Pharmaceutical Technology Co., LTD
Tel
18661161657
Email
yaoxiangqiu2021@163.com
Country
China
ProdList
9968
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
13986652530
Email
zhangweiyue@hdimpurity.com
Country
China
ProdList
7930
Advantage
58
Hubei Moco Chemical Co., Ltd.
Tel
18627753421; 18627756402
Fax
QQ：3001051413
Email
3001051413@qq.com
Country
China
ProdList
20319
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
+8618627948422
Email
sale@hdimpurity.com
Country
China
ProdList
3681
Advantage
58
More
Less

View Lastest Price from Tofacitinib Impurity 69 manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Tofacitinib Impurity 69
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-05-20

Tofacitinib Impurity 69Related Search:

3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE Tofacitinib Impurity 6

  • Tofacitinib Impurity 69
  • (E)-2,4-dichlorobut-2-enal